Nasdaq Helsinki
Every company in the roster listed on Nasdaq Helsinki.
Every company in the roster listed on Nasdaq Helsinki.
1 of 1 companies
| Company | Pipeline | Most advanced | Next readout | Market cap | Cash & inv. | Runway | R&D / yr |
|---|---|---|---|---|---|---|---|
Orion CorporationORNBV · Nasdaq Helsinki | 2 assets: 1 approved, 1 Ph 3 | LevosimendanPhase 3 · Heart FailurePartial signal | 30 Jun 2028Levosimendan · Phase 3 | — | $189MDec 2025 | — | $239M |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov). Cash shows its balance-sheet month; runway shows a month only when it comes from an earlier report.